Status:
RECRUITING
Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer
Lead Sponsor:
Jagiellonian University
Conditions:
Testicular Cancer
Eligibility:
MALE
18+ years
Brief Summary
This study aims to evaluate how retroperitoneal lymph node dissection (RPLND), a surgical treatment for testicular cancer, may affect urinary and sexual functions in men. RPLND involves the removal of...
Detailed Description
This is a prospective observational study designed to evaluate the impact of retroperitoneal lymph node dissection (RPLND) on lower urinary tract and sexual function in patients treated for testicular...
Eligibility Criteria
Inclusion
- Adult male with testicular cancer undergoing retroperitoneal lymph node dissection (RPLND)
Exclusion
- History of RPLND
- Lack of consent
Key Trial Info
Start Date :
May 14 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06954233
Start Date
May 14 2025
End Date
December 1 2027
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jagiellonian University Medical College
Krakow, Malopolska, Poland, 30-688